- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Alpha waves.
Displaying page 1 of 1.
EudraCT Number: 2009-018162-34 | Sponsor Protocol Number: 2010B257 | Start Date*: 2011-03-11 |
Sponsor Name:Thorax Center, Univeristy Medical Center Groningen, Groningen, The Netherlands | ||
Full Title: Metabolic modulation with metformin to reduce heart failure after acute myocardial infarction: Glycometabolic Intervention as adjunct to Primary percutaneous coronary intervention in ST elevation m... | ||
Medical condition: preservation and remodeling of the left ventricles after acute myocardial infarction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005197-11 | Sponsor Protocol Number: SENC | Start Date*: 2015-04-24 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII | |||||||||||||
Full Title: Sugammadex and neurogical effects central | |||||||||||||
Medical condition: patient undergoing elective surgery for which has been indicated only the general anesthesia with tracheal intubation and curarization | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2023-000062-34 | Sponsor Protocol Number: Reb-Oxy-OSA | Start Date*: 2023-06-02 | |||||||||||
Sponsor Name:CHU Brugmann | |||||||||||||
Full Title: Combination of Reboxetine 4mg and Oxybutynin 5mg for treating moderate obstructive sleep apnea: a one-month randomized placebo-controlled double-blind study | |||||||||||||
Medical condition: Obstructive sleep apnea | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001381-26 | Sponsor Protocol Number: CER-001-CLIN-010 | Start Date*: 2015-07-22 |
Sponsor Name:CERENIS THERAPEUTICS SA | ||
Full Title: A PHASE II MULTI-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FOCUSING TRIAL OF CER-001 IN SUBJECTS WITH ACUTE CORONARY SYNDROME | ||
Medical condition: Acute Coronary Syndrome (ACS) with significant plaque volume | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) NL (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
